WO2000017355A3 - Proteines humaines associees au cytosquelette - Google Patents

Proteines humaines associees au cytosquelette Download PDF

Info

Publication number
WO2000017355A3
WO2000017355A3 PCT/US1999/021565 US9921565W WO0017355A3 WO 2000017355 A3 WO2000017355 A3 WO 2000017355A3 US 9921565 W US9921565 W US 9921565W WO 0017355 A3 WO0017355 A3 WO 0017355A3
Authority
WO
WIPO (PCT)
Prior art keywords
associated proteins
cyskp
cytoskeleton associated
human cytoskeleton
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/021565
Other languages
English (en)
Other versions
WO2000017355A2 (fr
Inventor
Preeti Lal
Y Tom Tang
Henry Yue
Jennifer L Hillman
Olga Bandman
Neil C Corley
Karl J Guegler
Chandra Patterson
Yalda Azimzai
Mariah R Baughn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Priority to CA002343360A priority Critical patent/CA2343360A1/fr
Priority to EP99969440A priority patent/EP1114158A2/fr
Priority to AU60487/99A priority patent/AU6048799A/en
Priority to JP2000574254A priority patent/JP2002526076A/ja
Publication of WO2000017355A2 publication Critical patent/WO2000017355A2/fr
Publication of WO2000017355A3 publication Critical patent/WO2000017355A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des protéines humaines associées au cytosquelette (CYSKP), ainsi que des polynucléotides identifiant et codant ces protéines CSKP. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne enfin des méthodes permettant de diagnostiquer, de traiter ou de prévenir les troubles associés à l'expression de ces protéines.
PCT/US1999/021565 1998-09-18 1999-09-17 Proteines humaines associees au cytosquelette Ceased WO2000017355A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002343360A CA2343360A1 (fr) 1998-09-18 1999-09-17 Proteines humaines associees au cytosquelette
EP99969440A EP1114158A2 (fr) 1998-09-18 1999-09-17 Proteines humaines associees au cytosquelette
AU60487/99A AU6048799A (en) 1998-09-18 1999-09-17 Human cytoskeleton associated proteins
JP2000574254A JP2002526076A (ja) 1998-09-18 1999-09-17 ヒト細胞骨格関連タンパク質

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17222698P 1998-09-18 1998-09-18
US13132999P 1999-04-27 1999-04-27
US60/172,226 1999-04-27
US60/131,321 1999-04-27

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/921,707 Division US20050003447A1 (en) 1998-09-18 2004-08-19 Human cytoskeleton associated proteins

Publications (2)

Publication Number Publication Date
WO2000017355A2 WO2000017355A2 (fr) 2000-03-30
WO2000017355A3 true WO2000017355A3 (fr) 2000-07-06

Family

ID=26829372

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/021565 Ceased WO2000017355A2 (fr) 1998-09-18 1999-09-17 Proteines humaines associees au cytosquelette

Country Status (1)

Country Link
WO (1) WO2000017355A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7745579B1 (en) 1998-09-01 2010-06-29 David Wallach Inhibitor of NF-KB activation
JP2004519217A (ja) * 2000-08-21 2004-07-02 インサイト・ゲノミックス・インコーポレイテッド 微小管関連タンパク質およびチューブリン
US20040044184A1 (en) * 2000-10-27 2004-03-04 Baughn Mariah R Cytoskeleton-associated proteins
WO2002053719A2 (fr) * 2001-01-04 2002-07-11 Incyte Genomics, Inc. Proteines associees au cytosquelette
EP1373306A4 (fr) * 2001-03-29 2005-07-20 Incyte Genomics Inc Proteines associees au cytoskeleton
CA2399569A1 (fr) 2001-09-25 2003-03-25 Yusuke Nakamura Marqueurs diagnostiques et cibles therapeutiques pour le traitement du cancer
CN1628179B (zh) 2001-09-25 2011-04-20 肿瘤疗法科学股份有限公司 肝细胞癌的检测
WO2004016781A1 (fr) * 2002-08-13 2004-02-26 Riken Proteines d'origine humaine formant un domaine et leur utilisation
TWI350373B (en) 2004-01-23 2011-10-11 Oncotherapy Science Inc Methods of detecting methyl transferase activity and methods of screening formethyl transferase activity modulators
WO2006092958A1 (fr) 2005-02-28 2006-09-08 Oncotherapy Science, Inc. Gene znfn3a1 associe au cancer du sein
TW200741009A (en) 2005-07-01 2007-11-01 Oncotherapy Science Inc Methods of modulating SMYD3 for treatment of cancer
EP2171082B1 (fr) 2007-06-14 2012-11-28 Oncotherapy Science, Inc. Procedes d'identification d'agents qui modulent la methylation de vegfr1 par smyd3
US20140030192A1 (en) * 2011-01-28 2014-01-30 Karl A. Deisseroth Functional Targeted Brain Endoskeletonization
KR102148747B1 (ko) 2012-08-09 2020-08-27 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 현미경적 분석을 위한 생물학적 표본을 준비하기 위한 방법과 조성물
CN106164736A (zh) 2014-05-30 2016-11-23 斯坦福大学托管董事会 用于对大的完整组织样品进行成像的方法及装置
WO2017139501A1 (fr) 2016-02-10 2017-08-17 The Board Of Trustees Of The Leland Stanford Junior University Fixation et détection d'arn dans des tissus d'hydrogel basés sur le procédé clarity

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999028458A1 (fr) * 1997-11-27 1999-06-10 Chugai Seiyaku Kabushiki Kaisha Gene provenant de chondrocytes foetaux humain

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999028458A1 (fr) * 1997-11-27 1999-06-10 Chugai Seiyaku Kabushiki Kaisha Gene provenant de chondrocytes foetaux humain
AU1261599A (en) * 1997-11-27 1999-06-16 Chugai Seiyaku Kabushiki Kaisha Gene originating in human fetal chondrocytes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YASUHIKO KOYANO ET AL.: "Molecular cloning and characterization of CDEP, a novel human protein containing the Ezrin-like domain of the band 4.1 superfamily and the Dbl homology domain of Eho Guanine Nucleoide Exchange Factors.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 241, no. 2, 18 December 1997 (1997-12-18), ORLANDO, FL US, pages 369 - 375, XP002124973 *

Also Published As

Publication number Publication date
WO2000017355A2 (fr) 2000-03-30

Similar Documents

Publication Publication Date Title
WO1999061471A3 (fr) Proteines transmembranaires humaines
WO2001012662A3 (fr) Proteines associees a la membrane
WO2000015793A3 (fr) Proteines gpcr humaines
WO2000018922A3 (fr) Proteines humaines associees a des glucides
WO2000021988A3 (fr) Proteine humaine de la famille des ankyrines
WO2000034477A3 (fr) Proteines associees a des neurones
WO1999058692A3 (fr) Proteines associees a l'apoptose humaine
WO2000012711A8 (fr) Proteines membranaires de canal humaines
WO2000009709A3 (fr) Proteases et proteines associees
WO2000017355A3 (fr) Proteines humaines associees au cytosquelette
WO2000012703A3 (fr) Molecules associees au transport de proteines
WO2000026245A3 (fr) Proteines de transport membranaire
WO2000014251A3 (fr) Transferases humaines
WO2000052151A3 (fr) Proteines de secretion humaines
WO2000000594A3 (fr) Transferases humaines
WO1999058558A3 (fr) Proteines de signalisation cellulaire
WO1999061614A3 (fr) Proteines socs humaines
WO2000031263A3 (fr) Proteines associees a la gtpase
WO2000020604A3 (fr) Molecules d'oxydoreductase
WO2000028045A3 (fr) Hydrolases humaines
WO1999041373A3 (fr) Molecules humaines associees au transport
WO2000065054A3 (fr) Proteines humaines associees aux membranes
WO2000001821A3 (fr) Proteines associees a la neurotransmission
WO2000008155A3 (fr) Proteines associees a un recepteur humain
WO2000011171A3 (fr) Proteines humaines associees a l'arn

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2343360

Country of ref document: CA

Ref country code: CA

Ref document number: 2343360

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 574254

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999969440

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09786797

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999969440

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999969440

Country of ref document: EP